Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,869 | -29,164 | -13,319 | 1,903,000 | -1,473,000 |
| Depreciation Amortization | 612 | 271 | 123 | 2,175,000 | 861,000 |
| Accounts receivable | -8 | -300 | -87 | -83,000 | 21,000 |
| Accounts payable and accrued liabilities | 549 | 1,339 | 170 | N/A | N/A |
| Other Working Capital | 2,448 | 1,338 | 112 | -681,000 | -66,000 |
| Other Operating Activity | 3,567 | 4,489 | 723 | 50,000 | 3,287,000 |
| Operating Cash Flow | $-32,701 | $-22,027 | $-12,278 | $3,364,000 | $2,630,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,005 | 24,252 | -20,270 | 27,000 | 3,308,000 |
| PPE Investments | -789 | -1,991 | -217 | -462,000 | -616,000 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -15,789,000 |
| Other Investing Activity | 0 | 0 | 0 | -97,000 | -59,000 |
| Investing Cash Flow | $-11,794 | $22,261 | $-20,486 | $-532,000 | $-13,156,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -929,000 | 6,430,000 |
| Common Stock Issued | 170 | 185 | 10 | 15,000 | 1,762,000 |
| Common Stock Repurchased | -1,450 | N/A | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -572,000 | -481,000 |
| Other Financing Activity | 125,865 | 0 | 39,760 | -174,000 | 2,378,000 |
| Financing Cash Flow | $124,585 | $185 | $39,770 | $-1,660,000 | $10,089,000 |
| Exchange Rate Effect | N/A | N/A | N/A | -78,000 | 50,000 |
| Beginning Cash Position | 16,268 | 15,849 | 8,843 | 2,279,000 | 2,666,000 |
| End Cash Position | 96,358 | 16,268 | 15,849 | 3,373,000 | 2,279,000 |
| Net Cash Flow | $80,090 | $419 | $7,006 | $1,094,000 | $-387,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,701 | -22,027 | -12,278 | 3,364,000 | 2,630,000 |
| Capital Expenditure | -789 | -1,991 | -217 | -747,000 | -618,000 |
| Free Cash Flow | -33,490 | -24,018 | -12,494 | 2,617,000 | 2,012,000 |